Search Results 221-230 of 1682 for ai产品榜官网,可以ai绘画的网站,ai自学教程网,最好用的ai网站,ai语音生成网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  2. Laboratories - Mayo Clinic Research

    Data Analytics and AI for Advanced Liver Disease: Vijay Shah, Patrick Kamath, Douglas Simonetto, Alina Allen · Developmental Endoscopy Laboratory: Elizabeth ...

  3. Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    About this study. RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to ...

  4. Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score - Mayo Clinic

    Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling ...

  5. Publications - Yajue Huang, M.D., Ph.D. - Mayo Clinic

    ... AI, Zhang B, Whiteaker JR, Fenyo D, McKerrow W, Wang J, Schurer SC, Stathias V, Chen XS, Barcellos-Hoff MH, Starr TK, Winterhoff BJ, Nelson AC, Mok SC ...

  6. A Study to Evaluate Oxygen Supplementation Duration to Assess Resolution of Acute Hypoxic Respiratory Failure - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer - Mayo Clinic

    This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer ...

  8. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

  9. Joel Streed | Mayo Clinic News Network - Page 114 of 170

    He is a former broadcast journalist and news director. Joel has been with Mayo Clinic since 2001, first as a contract employee and then officially joining the ...

  10. Yucai Wang, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    D., is an Associate Professor of Medicine and Oncology and a Consultant in the Division of Hematology. He has received numerous honors and awards for his ...